-
Something wrong with this record ?
Calcium channel blockers do not protect against saturated fatty acid-induced ER stress and apoptosis in human pancreatic β-cells
J. Šrámek, V. Němcová, J. Kovář
Language English Country Great Britain
Document type Journal Article
Grant support
PROGRES Q36
Univerzita Karlova v Praze
NLK
BioMedCentral
from 2004-12-01
BioMedCentral Open Access
from 2004
Directory of Open Access Journals
from 2004
Free Medical Journals
from 2004
PubMed Central
from 2004
Europe PubMed Central
from 2004
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2004-08-01
Open Access Digital Library
from 2004-01-01
Open Access Digital Library
from 2004-01-01
Medline Complete (EBSCOhost)
from 2004-08-17
Nursing & Allied Health Database (ProQuest)
from 2009-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2004
Springer Nature OA/Free Journals
from 2004-12-01
- Publication type
- Journal Article MeSH
It was evidenced that saturated fatty acids (FAs) have a detrimental effect on pancreatic β-cells function and survival, leading to endoplasmic reticulum (ER) calcium release, ER stress, and apoptosis. In the present study, we have tested the effect of three calcium influx inhibitors, i.e., diazoxide, nifedipine, and verapamil, on the apoptosis-inducing effect of saturated stearic acid (SA) in the human pancreatic β-cell lines NES2Y and 1.1B4. We have demonstrated that the application of all three calcium influx inhibitors tested has no inhibitory effect on SA-induced ER stress and apoptosis in both tested cell lines. Moreover, these inhibitors have pro-apoptotic potential per se at higher concentrations. Interestingly, these findings are in contradiction with those obtained with rodent cell lines and islets. Thus our data obtained with human β-cell lines suggest that the prospective usage of calcium channel blockers for prevention and therapy of type 2 diabetes mellitus, developed with the contribution of the saturated FA-induced apoptosis of β-cells, seems rather unlikely.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024361
- 003
- CZ-PrNML
- 005
- 20211013133948.0
- 007
- ta
- 008
- 211006s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12986-021-00597-6 $2 doi
- 035 __
- $a (PubMed)34274001
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Šrámek, Jan $u Department of Biochemistry, Cell and Molecular Biology and Center for Research of Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic. jan.sramek@lf3.cuni.cz
- 245 10
- $a Calcium channel blockers do not protect against saturated fatty acid-induced ER stress and apoptosis in human pancreatic β-cells / $c J. Šrámek, V. Němcová, J. Kovář
- 520 9_
- $a It was evidenced that saturated fatty acids (FAs) have a detrimental effect on pancreatic β-cells function and survival, leading to endoplasmic reticulum (ER) calcium release, ER stress, and apoptosis. In the present study, we have tested the effect of three calcium influx inhibitors, i.e., diazoxide, nifedipine, and verapamil, on the apoptosis-inducing effect of saturated stearic acid (SA) in the human pancreatic β-cell lines NES2Y and 1.1B4. We have demonstrated that the application of all three calcium influx inhibitors tested has no inhibitory effect on SA-induced ER stress and apoptosis in both tested cell lines. Moreover, these inhibitors have pro-apoptotic potential per se at higher concentrations. Interestingly, these findings are in contradiction with those obtained with rodent cell lines and islets. Thus our data obtained with human β-cell lines suggest that the prospective usage of calcium channel blockers for prevention and therapy of type 2 diabetes mellitus, developed with the contribution of the saturated FA-induced apoptosis of β-cells, seems rather unlikely.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Němcová, Vlasta $u Department of Biochemistry, Cell and Molecular Biology and Center for Research of Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Kovář, Jan $u Department of Biochemistry, Cell and Molecular Biology and Center for Research of Diabetes, Metabolism, and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic. jan.kovar@lf3.cuni.cz
- 773 0_
- $w MED00165928 $t Nutrition & metabolism $x 1743-7075 $g Roč. 18, č. 1 (2021), s. 74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34274001 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013133945 $b ABA008
- 999 __
- $a ind $b bmc $g 1708291 $s 1144858
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 18 $c 1 $d 74 $e 20210717 $i 1743-7075 $m Nutrition & metabolism $n Nutr Metab $x MED00165928
- GRA __
- $a PROGRES Q36 $p Univerzita Karlova v Praze
- LZP __
- $a Pubmed-20211006